Jason Melehani, a resident in internal medicine, has had a long and eclectic career path toward developing new therapies to treat tobacco smokers.
Category: Addiction
Stanford study shows the power of ecofriendly packaging for cigarettes
A new Stanford study shows that people incorrectly think cigarettes with ecofriendly packaging are healthier and less harmful to the environment.
From prison to Stanford postdoc — a journey in recovery
Researcher joins Stanford Medicine as a postdoctoral scholar in the Systems Neuroscience and Pain Lab to help others overcome addiction and incarceration.
Flavored e-cigs appeal to new nicotine users, Stanford study finds
New Stanford research suggests that young people begin using nicotine products like e-cigarettes by trying fruit, mint or candy flavors.
Taking Depression Seriously: Anxiety, addiction and chronic illness
Depression often occurs with other conditions such as anxiety, addiction or chronic illnesses, physician Randall Stafford and Sophia Xiao explain.
Cannabis is not the answer to opioid overdose deaths
Stanford researchers disprove the idea that legalizing medical marijuana will lead to fewer deaths from opioid overdoses.
E-cigarette flavors may boost risk of heart disease
E-cigarette flavorings are harmful to blood vessel cells even in the absence of nicotine. The flavors of cinnamon and menthol are particularly dangerous.
Promos spark teens’ use of nicotine products, Stanford study finds
Teenagers who owned promotional items for nicotine-containing products were twice as likely as other teens to start using the products.
National opioid group addresses challenge of addiction and pain management
Stanford anesthesiologist Edward Mariano discusses the progress and goals of the National Academy of Medicine's opioid collaborative.
Is the health care system ready for climate change?
Stanford medical student Dan Bernstein challenges health care professionals to take steps to mitigate and respond to climate change.
Doctors smoking? New exhibit displays now-startling ads
In response to views that cigarettes were unhealthful, tobacco companies used images of medical professionals to sell their products.
Can we address both chronic pain and the opioid crisis? Yes, pain doctors say
Stanford pain researchers say we can curb the prescription opioid crisis, while treating pain, by using a variety of tactics.
Nicotine’s effect on the developing embryo studied in new model
Using human embryonic stem cells to study nicotine's effect in development shows defects in cellular communication and longevity, say Stanford scientists.
Opioid epidemic makes eastern inroads and targets African-Americans
A new study has found that opioid-related deaths are highest on the East Coast and opioids are affecting an increasing number of African-Americans.
Juul instigated a “nicotine arms race”, researchers say
Experts studying nicotine and e-cigarette norms say that Juul has instigated a "nicotine arms race," causing a shift across the e-cigarette industry.
Heroin as a repugnant market: Is it time for a different solution?
Alvin Roth, a Nobel laureate and Stanford faculty member, explains how the economic concept of repugnant markets applies to heroin in the United States.